losartan has been researched along with perindopril in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (20.63) | 18.2507 |
2000's | 35 (55.56) | 29.6817 |
2010's | 11 (17.46) | 24.3611 |
2020's | 4 (6.35) | 2.80 |
Authors | Studies |
---|---|
Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Janiak, P; Pillon, A; Prost, JF; Vilaine, JP | 1 |
Bertram, JF; Black, MJ; Bobik, A; O'Sullivan, JB | 1 |
Janiak, P; Libert, O; Vilaine, JP | 1 |
Chauvin, B; Giudicelli, JF; Richer, C | 1 |
Anderson, NH; Bohr, DF; Devlin, AM; Dominiczak, AF; Lee, WK; Reid, JL | 1 |
Funder, JW; Young, MJ | 1 |
Black, MJ; Bobik, A; Kanellakis, P | 1 |
Cerutti, C; Ducher, M; Lantelme, P; Lo, M; Paultre, CZ | 1 |
Corradi, L; Fogari, R; Lazzari, P; Lusardi, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
Anderson, NH; Devlin, AM; Dominiczak, AF; Graham, D; Hamilton, CA; Morton, JJ; Reid, JL; Schork, NJ | 1 |
Heller, J; Hellerová, S | 1 |
Mackay, FJ; Mann, RD; Pearce, GL | 1 |
Altun, B; Arici, M; Cağlar, S; Erdem, Y; Haznedaroğlu, IC; Turgan, C; Usalan, C; Yasavul, U | 1 |
Henrion, D; Lévy, BI; Matrougui, K | 1 |
Chiang, YF; Lee, YJ; Tsai, JC | 1 |
Duhault, J; Lonchampt, M; Pennel, L | 1 |
Chanudet, X; De Champvallins, M | 1 |
Egashira, K; Ito, A; Muramatsu, K; Narishige, T; Takeshita, A | 1 |
Delbridge, LM; Griffiths, CD; Morgan, TO | 1 |
Laurent, S | 1 |
Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
Schiffrin, EL | 1 |
Bertram, D; Blanc-Brunat, N; Lo, M; Sassard, J | 1 |
Gurevich, MA | 1 |
Li, YJ; Liao, DF; Qin, XP; Ye, F | 1 |
Horie, H; Horie, M; Kinoshita, M; Matsumoto, T; Matsuo, S; Minai, K; Ohira, N; Ozawa, T; Takashima, H; Tarutani, Y; Yasuda, Y | 1 |
Li, X; Meng, Y; Wu, PS; Yang, XS; Zhang, ZS | 1 |
Delbridge, LM; Morgan, TO; Trongtorsak, P | 1 |
Hayashi, K; Homma, K; Kanda, T; Matsuda, H; Saruta, T; Takamatsu, I; Tatematsu, S; Wakino, S; Yoshioka, K | 1 |
Aronow, WS; Frishman, WH | 1 |
Chan, JS; Fantus, IG; Filep, JG; Fustier, P; Hamet, P; Hsieh, TJ; Ingelfinger, JR; Tang, SS; Wei, CC; Zhang, SL | 1 |
Chapuis, B; Liu, KL; Lo, M; Naelten, G | 1 |
Shimabukuro, M; Tagawa, T; Ueda, S; Watanabe, S; Yamakawa, K | 1 |
Araki, N; Fujimura, A; Ioka, T; Sugimoto, K; Tsuruoka, S; Wakaumi, M | 1 |
Lo, M; Naelten, G; Trigo, LF | 1 |
Brezniceanu, ML; Chan, JS; Filep, JG; Guo, DF; Hamet, P; Hsieh, TJ; Ingelfinger, JR; Liu, F; Liu, Q; Sachetelli, S; Sigmund, CD; Zhang, SL | 1 |
Dai, Y; Lan, XB; Ling, ZY; Liu, ZC; Luo, KL; Su, L; Wu, JJ; Yang, XY; Yin, YH | 1 |
Dai, Y; Dalal, D; Dong, J; Lan, X; Ling, Z; Liu, D; Liu, Z; Luo, K; She, Q; Su, L; Woo, K; Wu, J; Yin, Y | 1 |
Li, G; Liu, T | 1 |
Gopalam, M; Kanna, B | 1 |
Ismail, SB; Naing, L; Rahman, AR; Rehman, A; Roshan, TM | 1 |
Chiara Cavallini, M; Palmieri, V; Pini, R | 1 |
Brezniceanu, ML; Chan, JS; Chénier, I; Filep, JG; Ingelfinger, JR; Liu, F; Sachetelli, S; Wei, CC; Zhang, SL | 1 |
Cochain, C; Duriez, M; Lévy, BI; Loinard, C; Mees, B; Silvestre, JS; Vilar, J; You, D | 1 |
Cai, SX; Cheng, YX; Li, X; Meng, Y; Tong, WC | 1 |
Mourad, JJ; Waeber, B | 1 |
Jia, M; Li, L; Liu, RY; Lu, PQ; Zhang, JY; Zhao, XY | 1 |
Chou, PC; Hsiao, PJ; Hsieh, TJ; Hung, WW; Lin, KD; Lin, T; Shin, SJ | 1 |
Al-Ismaeel, H; Al-Rikabi, AC; Al-Shabanah, OA; Mansour, MA | 1 |
Chan, JS; Chenier, I; Filep, JG; Godin, N; Ingelfinger, JR; Liu, F; Lo, CS; Maachi, H; Shi, Y; Zhang, SL | 1 |
Huang, S; Li, C; Li, X; Li, Y; Luo, W; Ni, S | 1 |
Barykina, IN; Chumachok, EV; Ledyaeva, AA; Mazina, G; Nedogoda, SV; Salasyuk, AS; Tsoma, VV | 1 |
Csajági, E; Major, Z; Pavlik, G; Szauder, I; Ujhelyi, G | 1 |
Al-Sharea, A; Dart, AM; Du, XJ; Gao, XM; Han, LP; Kiriazis, H; Moore, S; Murphy, AJ; Su, Y; Tsai, A | 1 |
Abdelghany, RH; El-Ahwany, E; Goda, R; Helal, NS; Mahmoud, AAA; Saber, S | 1 |
Bourke, JP; Bueser, T; Quinlivan, R | 1 |
Aiglova, R; Cernicek, V; Danek, J; Gloger, V; Lazarova, M; Pavlu, L; Precek, J; Schee, A; Skala, T; Taborsky, M; Vicha, M | 1 |
Tchernev, G | 1 |
Ardiana, M; Harsoyo, PM; Hermawan, HO; Muhammad, AR; Sufiyah, IM; Suryawan, IGR; Zaini, BSI | 1 |
Alaba, OA; Gumedze, F; Jones, ESW; Ntusi, NAB; Snyman, JR; Tsabedze, N; Vira, A | 1 |
5 review(s) available for losartan and perindopril
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Atenolol; Biphenyl Compounds; Cilazapril; Humans; Hypertension; Irbesartan; Losartan; Perindopril; Tetrazoles | 2002 |
[Policy of antihypertensive therapy in arterial hypertension in the elderly. II].
Topics: Acrylates; Adrenergic alpha-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Doxazosin; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Perindopril; Risk Factors; Sex Factors; Sodium Chloride Symporter Inhibitors; Thiophenes | 2002 |
Treatment of hypertension and prevention of ischemic stroke.
Topics: Algorithms; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diltiazem; Humans; Hypertension; Losartan; Perindopril; Stroke | 2004 |
Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
Topics: Adolescent; Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiovascular Agents; Child; Disease Progression; Eplerenone; Human Growth Hormone; Humans; Lisinopril; Losartan; Male; Muscular Dystrophy, Duchenne; Non-Randomized Controlled Trials as Topic; Perindopril; Placebos; Randomized Controlled Trials as Topic; Stroke Volume; Ubiquinone; Young Adult | 2018 |
16 trial(s) available for losartan and perindopril
Article | Year |
---|---|
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Hemodynamics; Humans; Hypertension; Indoles; Insulin Resistance; Losartan; Male; Middle Aged; Obesity; Perindopril | 1998 |
Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Female; Fibrinolysis; Fibrinolytic Agents; Humans; Hypertension; Lipoproteins; Losartan; Male; Middle Aged; Perindopril; Plasminogen Activator Inhibitor 1; Thrombomodulin; Tissue Plasminogen Activator | 1999 |
Severe nonproductive cough and cough-induced stress urinary incontinence in diabetic postmenopausal women treated with ACE inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cough; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Hypertension; Losartan; Perindopril; Postmenopause; Prevalence; Prospective Studies; Urinary Incontinence, Stress | 2000 |
Antihypertensive efficacy and tolerability of low-dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indapamide; Losartan; Male; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2001 |
Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Bisoprolol; Blood Pressure; Endothelium, Vascular; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Nitric Oxide Synthase; Perindopril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; von Willebrand Factor | 2001 |
Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Humans; Hypertension; Indapamide; Losartan; Perindopril; Safety; Time Factors | 2001 |
Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril; Plasminogen Activator Inhibitor 1 | 2002 |
Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bradykinin; Coronary Circulation; Dose-Response Relationship, Drug; Female; Fibrinolysis; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril; Receptor, Angiotensin, Type 1; Tissue Plasminogen Activator | 2003 |
Differing anti-proteinuric action of candesartan and losartan in chronic renal disease.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Female; Humans; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Nitric Oxide; Perindopril; Proteinuria; Tetrazoles | 2003 |
Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans.
Topics: Acetylcholine; Adult; Anticoagulants; Antihypertensive Agents; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids, Nonesterified; Heparin; Humans; Lipids; Losartan; Male; omega-N-Methylarginine; Perindopril; Plethysmography; Regional Blood Flow; Renin-Angiotensin System; Vasodilation; Vasodilator Agents | 2005 |
Comparative study of taste disturbance by losartan and perindopril in healthy volunteers.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Asian People; Cross-Over Studies; Double-Blind Method; Humans; Losartan; Male; Middle Aged; Perindopril; Renin; Saliva; Taste Threshold; Zinc | 2005 |
[Long-term clinical efficacy of losartan or perindopril combination therapy with low-dose amiodarone in patients with paroxysmal atrial fibrillation].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Losartan; Male; Middle Aged; Perindopril; Prospective Studies | 2006 |
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Drug Therapy, Combination; Female; Heart Atria; Humans; Losartan; Male; Middle Aged; Perindopril; Prospective Studies; Secondary Prevention; Treatment Outcome | 2006 |
Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aorta; Double-Blind Method; Female; Humans; Hypertension; Losartan; Malaysia; Male; Perindopril; Polymorphism, Genetic; Pulse; Receptor, Angiotensin, Type 1 | 2007 |
Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Obesity; Overweight; Perindopril; Single-Blind Method; Telmisartan | 2013 |
Treatment of Hypertension: Favourable Effect of the Twice-Daily Compared to the Once-Daily (Evening) Administration of Perindopril and Losartan.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Administration Schedule; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril | 2015 |
42 other study(ies) available for losartan and perindopril
Article | Year |
---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Role of angiotensin subtype 2 receptor in neointima formation after vascular injury.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Carotid Arteries; Carotid Artery Injuries; Catheterization; Hyperplasia; Imidazoles; Indoles; Losartan; Male; Oligopeptides; Perindopril; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles; Tunica Intima | 1992 |
Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Body Weight; Cardiomegaly; Hypertension, Renovascular; Hypertrophy; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred WKY; Tetrazoles | 1994 |
Role of the renin-angiotensin system in neointima formation after injury in rabbits.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Bradykinin; Heart Rate; Imidazoles; Indoles; Losartan; Male; Oligopeptides; Perindopril; Rabbits; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Tunica Intima; Wound Healing | 1994 |
Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Decerebrate State; Hemodynamics; Hypertension; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred SHR; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles; Vasoconstriction | 1995 |
Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiomegaly; Female; Hypertension; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Polyploidy; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1996 |
The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis.
Topics: Aldosterone; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Canrenoic Acid; Cardiomegaly; Collagen; Corticosterone; Epithelium; Fibrosis; Heart; Imidazoles; Indoles; Losartan; Male; Myocardium; Nephrectomy; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renin-Angiotensin System; Tetrazoles | 1996 |
Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Body Weight; Cardiomegaly; Cardiovascular System; Hypertension; Hypertrophy; Indoles; Kidney; Losartan; Male; Mesenteric Arteries; Organ Size; Papaverine; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Vascular Resistance | 1997 |
Mechanisms of spontaneous baroreflex impairment in lyon hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Heart Rate; Hypertension; Indoles; Losartan; Male; Perindopril; Rats | 1998 |
Telemetry for cardiovascular monitoring in a pharmacological study: new approaches to data analysis.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Cell Nucleus; Diastole; DNA; Female; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Indoles; Losartan; Lymphocytes; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Perindopril; Rats; Rats, Inbred SHR; Systole; Telemetry; Time Factors | 1999 |
Long-term effect on blood pressure of early brief treatment by different antihypertensive agents: a study in the prague hypertensive rat.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Genetic Predisposition to Disease; Hypertension; Indoles; Losartan; Male; Perindopril; Rats; Rats, Inbred Strains; Time Factors | 1998 |
Cough and angiotensin II receptor antagonists: cause or confounding?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cohort Studies; Confounding Factors, Epidemiologic; Cough; Data Collection; Drug Monitoring; Enalapril; Female; Humans; Indoles; Lisinopril; Losartan; Male; Middle Aged; Perindopril | 1999 |
Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Viscosity; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Imidazoles; Losartan; Mesenteric Arteries; Muscle Tonus; Perindopril; Phenylpropionates; Pyridines; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Splanchnic Circulation; Vascular Resistance; Vasodilation | 2000 |
Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Cell Count; Dextrans; Endothelium; Fluoresceins; Humans; Hyperoxia; Hypoxia; Imidazoles; Infant, Newborn; Losartan; Mice; Mice, Inbred C57BL; Perindopril; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Retinal Ganglion Cells; Retinal Neovascularization; Retinopathy of Prematurity | 2001 |
Effects of combined administration of ACE inhibitor and angiotensin II receptor antagonist are prevented by a high NaCl intake.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Behavior, Animal; Blood; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Drug Synergism; Eating; Heart; Losartan; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2001 |
Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diuresis; Glomerulosclerosis, Focal Segmental; Hypertension, Renal; Kidney; Kidney Diseases; Losartan; Male; Natriuresis; Perindopril; Proteinuria; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2002 |
Involvement of calcitonin gene-related peptide in the depressor effects of losartan and perindopril in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcitonin Gene-Related Peptide; Gene Expression; Hypertension, Renovascular; Losartan; Male; Perindopril; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2003 |
[Effect of ACE-I and AT-1 receptor blocker on the progression of CCl(4)-inducing rat hepatic fibrogenesis].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Carbon Tetrachloride Poisoning; Hyaluronic Acid; Laminin; Liver Cirrhosis, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Perindopril; Rats; Rats, Wistar | 2003 |
Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Body Weight; Dose-Response Relationship, Drug; Heart; Losartan; Male; Myocardial Contraction; Myocytes, Cardiac; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sodium, Dietary | 2003 |
Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Azaserine; Cell Line; Gene Expression Regulation; Glucose; Imidazoles; Indicators and Reagents; Indoles; Insulin; Kidney Tubules, Proximal; Losartan; Maleimides; Perindopril; Protein Kinase C; Pyridines; Rats; Reactive Oxygen Species; Renin | 2004 |
Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Therapy, Combination; Hypertension; Kidney; Losartan; Male; Perindopril; Rats; Renin-Angiotensin System | 2005 |
Blood pressure and proteinuria after cessation of a brief renin-angiotensin system blockade in young and adult Lyon hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Losartan; Male; Perindopril; Proteinuria; Rats; Renin-Angiotensin System; Time Factors | 2005 |
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Blotting, Western; DNA, Complementary; Female; Gene Expression Regulation; Hypertension; Immunohistochemistry; Kidney; Kidney Diseases; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Perindopril; Proteins; Proteinuria; Rats; Renin-Angiotensin System | 2006 |
Anti-inflammatory effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Potential benefits for the prevention of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Combinations; Humans; Losartan; Perindopril; Randomized Controlled Trials as Topic | 2006 |
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Humans; Losartan; Perindopril; Prospective Studies; Randomized Controlled Trials as Topic; Secondary Prevention | 2007 |
Pulsology reloaded: commentary on similar effects of treatment on central and brachial blood pressure in older hypertensive subjects.
Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Losartan; Manometry; Perindopril; Ultrasonography, Doppler | 2007 |
Overexpression of angiotensinogen increases tubular apoptosis in diabetes.
Topics: Albuminuria; Angiotensinogen; Animals; Antihypertensive Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blood Glucose; Cell Line, Transformed; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hydralazine; Hypertension, Renal; Hypoglycemic Agents; Insulin; Kidney Tubules, Proximal; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Perindopril; Rats; Renin-Angiotensin System | 2008 |
Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bone Marrow Cells; Cell Differentiation; Disease Models, Animal; Endothelium, Vascular; Hindlimb; Hydralazine; Hypertension; Ischemia; Ligation; Losartan; Male; Neovascularization, Physiologic; Oxidative Stress; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stem Cells | 2008 |
[Perindopril and losartan attenuate bleomycin A5-induced pulmonary fibrosis in rats].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Bleomycin; Blotting, Western; Losartan; Male; NF-kappa B; Perindopril; Pulmonary Fibrosis; Random Allocation; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Transforming Growth Factor beta1 | 2008 |
Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Double-Blind Method; Drug Therapy, Combination; France; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Losartan; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Effects of combination therapy with perindopril and losartan on left ventricular remodelling in patients with myocardial infarction.
Topics: Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Perindopril; Prospective Studies; Treatment Outcome; Ultrasonography; Ventricular Remodeling | 2009 |
Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adipokines; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Apelin; Captopril; Cells, Cultured; Imidazoles; Intercellular Signaling Peptides and Proteins; Lipid Metabolism; Losartan; Mice; Perindopril; Pyridines; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; RNA, Messenger | 2011 |
Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver.
Topics: alpha-Fetoproteins; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticarcinogenic Agents; Captopril; Carcinoembryonic Antigen; Endostatins; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factors; Hydroxyproline; Liver; Liver Neoplasms, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Metallothionein; Perindopril; Precancerous Conditions; Rats; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2011 |
Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression; Hypertension; Kidney; Kidney Tubules, Proximal; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nephrosclerosis; Peptidyl-Dipeptidase A; Perindopril; Rats; Renin-Angiotensin System; Transgenes | 2012 |
[Perindopril and losartan attenuate intrahepatic Toll-like receptor 4 protein expression in rats with bile duct ligation-induced hepatic fibrosis].
Topics: Animals; Bile Ducts; Down-Regulation; Ligation; Liver Cirrhosis, Experimental; Losartan; Male; Perindopril; Rats; Rats, Wistar; Toll-Like Receptor 4 | 2012 |
Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rupture, Post-Infarction; Inflammation; Inflammation Mediators; Losartan; Male; Mice, 129 Strain; Monocytes; Myocardial Infarction; Myocardium; Neutrophil Infiltration; Neutrophils; Perindopril; Renin-Angiotensin System; Spleen; Time Factors | 2017 |
Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cyclin D1; Diethylnitrosamine; Fosinopril; Liver Neoplasms, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; Niacinamide; Perindopril; Phenylurea Compounds; Phosphorylation; Renin-Angiotensin System; Signal Transduction; Sorafenib; Time Factors; Transcription Factor RelA; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2018 |
Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic.
Topics: Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Antihypertensive Agents; Czech Republic; Heart Failure; Humans; Losartan; Neprilysin; Perindopril; Ramipril; Retrospective Studies; Telmisartan; Valsartan | 2022 |
NITROSOGENESIS OF SKIN CANCER: THE NITROSAMINE CONTAMINATION IN THE CALCIUM CHANNEL BLOCKERS (AMLODIPINE), BETA BLOCKERS (BISOPROLOL), SARTANS (VALSARTAN/LOSARTAN), ACE INHIBITORS (PERINDOPRIL/ENALAPRIL), TRICYCLIC ANTIDEPRESSANTS (MELITRACEN), SSRIS (PAR
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Tricyclic; Bisoprolol; Calcium Channel Blockers; Enalapril; Humans; Incidence; Losartan; Metformin; Paroxetine; Perindopril; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Skin Neoplasms; Valsartan; Venlafaxine Hydrochloride | 2023 |
Perindopril and losartan attenuate pro-coagulation factors in human adipocytes exposed to SARS-CoV-2 spike protein.
Topics: Adipocytes; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Blood Coagulation Factors; Cardiovascular Agents; COVID-19; Humans; Losartan; Male; Obesity; Perindopril; Plasminogen Activator Inhibitor 1; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Thromboplastin | 2023 |
Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Enalapril; Humans; Hypertension; Losartan; Perindopril; South Africa | 2023 |